Back to Trades
Other4
Pasithea Therapeutics Corp.
KTTA
Total Value
$226.8K
Company Information
- Company Name
- Pasithea Therapeutics Corp.
- Ticker Symbol
- KTTA
- CIK
- 0001841330
Insider Information
- Role
- Chief Financial Officer
- Location
- MIAMI BEACH, FL
Officer
Filing Details
- Filing Date
- Oct 27, 2025
- Transaction Date
- Oct 24, 2025
- Accession Number
- 0001213900-25-102681
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Oct 24, 2025 | Derivative | 317,266 | $0.71 | Grant/Award | $226.8K |
Footnotes
- (F1)The option (the "Option") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the "Plan"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and the remaining shares will vest in equal quarterly installments thereafter for the next two years; provided, that the Reporting Person remains in continuous service to the Issuer through such vesting dates; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan). Additionally, all vested and exercisable shares underlying the Option held by the grantee may be exercised by the grantee for a period of up until three (3) years following termination of Continuous Service (as defined in the Plan), other than a termination for Cause (as defined in the Plan).